WittGen
2 known investors
Find your way into WittGen
Sign up to see every warm intro you have to WittGen
- Paths you didn't know you had: your email and LinkedIn already hold routes to the WittGen team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Wittgen Bio applies single-cell generative AI to reconstruct cellular-level profiles from bulk RNA or image samples, producing virtual patient profiling for patient stratification. It targets clinical trial teams in oncology, aiming to de-risk trials by identifying responder populations and extracting biomarkers from existing samples.
Founders & leadership
Investors · 2
Frequently asked questions
- What does WittGen do?
- Wittgen Bio applies single-cell generative AI to reconstruct cellular-level profiles from bulk RNA or image samples, producing virtual patient profiling for patient stratification. It targets clinical trial teams in oncology, aiming to de-risk trials by identifying responder populations and extracting biomarkers from existing samples.
- Who founded WittGen?
- WittGen was founded by Yun Rhie, Minwoo Jung.
- Who are WittGen's investors?
- WittGen's investors include PharmStars Ventures, Plug and Play Ventures.
